Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome.
about
Efficacy, safety, and applicability of outpatient treatment for diverticulitisBrain-gut microbiome interactions and functional bowel disordersMicroencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis--a prospective randomized study.New physiopathological and therapeutic approaches to diverticular disease: an update.Management of traveller's diarrhoea with a combination of sodium butyrate, organic acids, and A-300 silicon dioxideButyric acid - a well-known molecule revisited.
P2860
Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Microencapsulated sodium butyr ...... with irritable bowel syndrome.
@ast
Microencapsulated sodium butyr ...... with irritable bowel syndrome.
@en
type
label
Microencapsulated sodium butyr ...... with irritable bowel syndrome.
@ast
Microencapsulated sodium butyr ...... with irritable bowel syndrome.
@en
prefLabel
Microencapsulated sodium butyr ...... with irritable bowel syndrome.
@ast
Microencapsulated sodium butyr ...... with irritable bowel syndrome.
@en
P2093
P2860
P50
P1433
P1476
Microencapsulated sodium butyr ...... with irritable bowel syndrome.
@en
P2093
B F Kaczmarek
P Krokowicz
T Banasiewicz
Ł Krokowicz
P2860
P304
P356
10.1111/J.1463-1318.2012.03152.X
P577
2013-02-01T00:00:00Z